person · Reporting owner

Rucker Michael A.

Disclosed activity across 2 companies

Tapewire entity: 23529
SEC CIK: 0001588247

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Pediatrix Medical Group, Inc.MD · Entity 4451	Director	August 12, 2026	August 14, 2026
Surgical Care Affiliates, Inc.SCAI · Entity 177510	Chief Operating Officer	March 24, 2017	March 24, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Pediatrix Medical Group, Inc.

Report date August 12, 2026 · Filed August 14, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	66,769	Reported balance After 2026-08-12 transaction · row 1 1 source row Row 1 · 2026-08-12 · Grant · Acquired 472 · Balance 66,769 F1: Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Surgical Care Affiliates, Inc.

Report date March 24, 2017 · Filed March 24, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	66,750	Reported balance After 2017-03-24 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2017-03-24 · Other · Disposed 30,934 · Balance 66,750 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F2: Pursuant to the Merger Agreement, each share of Common Stock was exchanged for $11.40 in cash and a number of shares of UHG common stock equal to $45.60 divided by $169.42, (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer), with the fractional shares being paid in cash, as provided in the Merger Agreement. F3: Includes 53,965 shares of Common Stock underlying restricted stock units ("RSUs") of the issuer, all of which are subject to time-based vesting and remained unvested mmediately prior to the effective time of the Merger (the "Effective Time"). Each RSU represents a contingent right to acquire one share of Common Stock.
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-03-24 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2017-03-24 · Disposition to issuer · Disposed 66,750 · Balance 0 F4: Disposed of in the Merger, pursuant to the Merger Agreement F5: Pursuant to the Merger Agreement, at the Effective Time each share of Common Stock was cancelled and converted into the right to receive $11.40 in cash and a number of shares of UHG common stock equal to $45.60 divided by $169.42, (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer), with the fractional shares being paid in cash, as provided in the Merger Agreement. F6: Pursuant to the Merger Agreement, at the Effective Time each outstanding and unvested RSU was cancelled and converted into that number of RSUs (rounded down to the nearest whole share) in respect of UHG common stock equal to the product of (x) the number of shares subject to such RSU immediately prior to the Effective Time and (y) $57 divided by $169.42 (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer) rounded down to the nearest whole share (such quotient, the "Equity Award Conversion Ratio").
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $12.10 · Expires 2018-09-15	Direct	0	Reported balance After 2017-03-24 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2017-03-24 · Disposition to issuer · Disposed 53,500 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F7: This line contains a combination of both time-based and performance-based options which, as of September 16, 2013, were fully vested.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $12.10 · Expires 2019-07-23	Direct	0	Reported balance After 2017-03-24 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-03-24 · Disposition to issuer · Disposed 37,765 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F9: This line contains a combination of both time-based and performance-based options which, as of September 16, 2013, were fully vested.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $8.72 · Expires 2021-02-08	Direct	0	Reported balance After 2017-03-24 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2017-03-24 · Disposition to issuer · Disposed 1,951 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F10: All of the options are time-based options which, as of February 8, 2016, were full vested.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $13.94 · Expires 2022-03-06	Direct	0	Reported balance After 2017-03-24 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2017-03-24 · Disposition to issuer · Disposed 23,696 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F11: All of the options are time-based options which, as of March 6, 2013, were fully vested.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $11.48 · Expires 2022-03-06	Direct	0	Reported balance After 2017-03-24 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2017-03-24 · Disposition to issuer · Disposed 24,928 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F12: All of the options are time-based options which, as of March 6, 2016, were fully vested.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $12.41 · Expires 2023-05-06	Direct	0	Reported balance After 2017-03-24 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2017-03-24 · Disposition to issuer · Disposed 73,170 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F13: Includes options for 54,877.5 shares of Common Stock that were vested prior to the Effective Time and options for 18,292.5 shares of Common Stock that remain unvested at the Effective Time. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F14: The option provides for vesting in equal annual installments on May 6, 2014, May 6, 2015, May 6, 2016 and May 6, 2017.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $29.02 · Expires 2024-09-17	Direct	0	Reported balance After 2017-03-24 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-03-24 · Disposition to issuer · Disposed 36,182 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F15: Includes options for 18,091 shares of Common Stock that were vested prior to the Effective Time and options for 18,091 shares of Common Stock that remain unvested at the Effective Time. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F16: The option provides for vesting in equal annual installments on September 17, 2015, September 17, 2016, September 17, 2017 and September 17, 2018.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $38.35 · Expires 2025-06-04	Direct	0	Reported balance After 2017-03-24 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-03-24 · Disposition to issuer · Disposed 28,365 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F17: Includes options for 7,091.25 shares of Common Stock that were vested prior to the Effective Time and options for 21,273.75 shares of Common Stock that remain unvested at the Effective Time. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F18: The option provides for vesting in equal annual installments on June 4, 2016, June 4, 2017, June 4, 2018 and June 4, 2019.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.25 · Expires 2026-03-02	Direct	0	Reported balance After 2017-03-24 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2017-03-24 · Disposition to issuer · Disposed 21,550 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F19: Includes options for 5,387.5 shares of Common Stock that were vested prior to the Effective Time and options for 16,162.5 shares of Common Stock that remain unvested at the Effective Time. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F20: The option provides for vesting in equal annual installments on March 2, 2017, March 2, 2018, March 2, 2019 and March 2, 2020.
Options to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $56.64 · Expires 2027-03-02	Direct	0	Reported balance After 2017-03-24 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2017-03-24 · Disposition to issuer · Disposed 14,396 · Balance 0 F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F21: All of these options remained unvested at the Effective Time. F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F22: The option provides for vesting in equal annual installments on March 2, 2018, March 2, 2019, March 2, 2020 and March 2, 2021.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC.

F2: Pursuant to the Merger Agreement, each share of Common Stock was exchanged for $11.40 in cash and a number of shares of UHG common stock equal to $45.60 divided by $169.42, (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer), with the fractional shares being paid in cash, as provided in the Merger Agreement.

F3: Includes 53,965 shares of Common Stock underlying restricted stock units ("RSUs") of the issuer, all of which are subject to time-based vesting and remained unvested mmediately prior to the effective time of the Merger (the "Effective Time"). Each RSU represents a contingent right to acquire one share of Common Stock.

F4: Disposed of in the Merger, pursuant to the Merger Agreement

F5: Pursuant to the Merger Agreement, at the Effective Time each share of Common Stock was cancelled and converted into the right to receive $11.40 in cash and a number of shares of UHG common stock equal to $45.60 divided by $169.42, (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer), with the fractional shares being paid in cash, as provided in the Merger Agreement.

F6: Pursuant to the Merger Agreement, at the Effective Time each outstanding and unvested RSU was cancelled and converted into that number of RSUs (rounded down to the nearest whole share) in respect of UHG common stock equal to the product of (x) the number of shares subject to such RSU immediately prior to the Effective Time and (y) $57 divided by $169.42 (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer) rounded down to the nearest whole share (such quotient, the "Equity Award Conversion Ratio").

F7: This line contains a combination of both time-based and performance-based options which, as of September 16, 2013, were fully vested.

F8: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio.

F9: This line contains a combination of both time-based and performance-based options which, as of September 16, 2013, were fully vested.

F10: All of the options are time-based options which, as of February 8, 2016, were full vested.

F11: All of the options are time-based options which, as of March 6, 2013, were fully vested.

F12: All of the options are time-based options which, as of March 6, 2016, were fully vested.

F13: Includes options for 54,877.5 shares of Common Stock that were vested prior to the Effective Time and options for 18,292.5 shares of Common Stock that remain unvested at the Effective Time.

F14: The option provides for vesting in equal annual installments on May 6, 2014, May 6, 2015, May 6, 2016 and May 6, 2017.

F15: Includes options for 18,091 shares of Common Stock that were vested prior to the Effective Time and options for 18,091 shares of Common Stock that remain unvested at the Effective Time.

F16: The option provides for vesting in equal annual installments on September 17, 2015, September 17, 2016, September 17, 2017 and September 17, 2018.

F17: Includes options for 7,091.25 shares of Common Stock that were vested prior to the Effective Time and options for 21,273.75 shares of Common Stock that remain unvested at the Effective Time.

F18: The option provides for vesting in equal annual installments on June 4, 2016, June 4, 2017, June 4, 2018 and June 4, 2019.

F19: Includes options for 5,387.5 shares of Common Stock that were vested prior to the Effective Time and options for 16,162.5 shares of Common Stock that remain unvested at the Effective Time.

F20: The option provides for vesting in equal annual installments on March 2, 2017, March 2, 2018, March 2, 2019 and March 2, 2020.

F21: All of these options remained unvested at the Effective Time.

F22: The option provides for vesting in equal annual installments on March 2, 2018, March 2, 2019, March 2, 2020 and March 2, 2021.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 12, 2026 Filed Aug 14, 2026 21:00 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	472	$26.50	$12,508.00	Disclosure SEC source: 0001193125-26-352526 · ownership.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,769 F1 · kind: Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027. Read SEC document
May 07, 2026 Filed May 11, 2026 21:43 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	7,196	$0.00	$0.00	Disclosure SEC source: 0001193125-26-217256 · ownership.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,297 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 7, 2027. Read SEC document
November 17, 2025 Filed Nov 19, 2025 22:00 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	SaleCommon Stock	10,478	$23.00	$240,994.00	Disclosure SEC source: 0001193125-25-288277 · ownership.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,101 F1 · price: The price in Colum 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $23.00 to $23.02 for a weighted average sales price of $23.00. The reporting person undertakes to provide the issuer, any security holder of the issuer of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 08, 2025 Filed May 12, 2025 21:00 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	11,427	$0.00	$0.00	Disclosure SEC source: 0000950170-25-069432 · ownership.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,579 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 8, 2026. Read SEC document
May 09, 2024 Filed May 13, 2024 21:00 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	18,360	$0.00	$0.00	Disclosure SEC source: 0000950170-24-058787 · ownership.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,152 F1 · kind: Restricted shares granted pursupant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 9, 2025. Read SEC document
May 11, 2023 Filed May 15, 2023 21:00 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	10,965	$0.00	$0.00	Disclosure SEC source: 0001209191-23-029513 · doc4.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,792 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 11, 2024. Read SEC document
May 12, 2022 Filed May 13, 2022 21:05 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	8,480	$0.00	$0.00	Disclosure SEC source: 0001209191-22-028908 · doc4.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,827 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2023. Read SEC document
May 12, 2021 Filed May 14, 2021 20:24 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	4,885	$0.00	$0.00	Disclosure SEC source: 0001209191-21-032719 · doc4.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,347 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest on May 12, 2022. Read SEC document
February 13, 2020 Filed Feb 18, 2020 23:08 UTC	Pediatrix Medical Group, Inc. MD · Entity 4451	GrantCommon Stock	4,717	$0.00	$0.00	Disclosure SEC source: 0001209191-20-010333 · doc4.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,462 F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	14,396	Not disclosed Strike: $56.64	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 12 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,396 shares Expires 2027-03-02 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F21 · shares: All of these options remained unvested at the Effective Time. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F22 · derivative.exercise_date: The option provides for vesting in equal annual installments on March 2, 2018, March 2, 2019, March 2, 2020 and March 2, 2021. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	21,550	Not disclosed Strike: $41.25	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 11 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,550 shares Expires 2026-03-02 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F19 · shares: Includes options for 5,387.5 shares of Common Stock that were vested prior to the Effective Time and options for 16,162.5 shares of Common Stock that remain unvested at the Effective Time. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F20 · derivative.exercise_date: The option provides for vesting in equal annual installments on March 2, 2017, March 2, 2018, March 2, 2019 and March 2, 2020. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	28,365	Not disclosed Strike: $38.35	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 10 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,365 shares Expires 2025-06-04 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F17 · shares: Includes options for 7,091.25 shares of Common Stock that were vested prior to the Effective Time and options for 21,273.75 shares of Common Stock that remain unvested at the Effective Time. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F18 · derivative.exercise_date: The option provides for vesting in equal annual installments on June 4, 2016, June 4, 2017, June 4, 2018 and June 4, 2019. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	36,182	Not disclosed Strike: $29.02	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 9 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,182 shares Expires 2024-09-17 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F15 · shares: Includes options for 18,091 shares of Common Stock that were vested prior to the Effective Time and options for 18,091 shares of Common Stock that remain unvested at the Effective Time. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F16 · derivative.exercise_date: The option provides for vesting in equal annual installments on September 17, 2015, September 17, 2016, September 17, 2017 and September 17, 2018. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	73,170	Not disclosed Strike: $12.41	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 8 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,170 shares Expires 2023-05-06 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F13 · shares: Includes options for 54,877.5 shares of Common Stock that were vested prior to the Effective Time and options for 18,292.5 shares of Common Stock that remain unvested at the Effective Time. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F14 · derivative.exercise_date: The option provides for vesting in equal annual installments on May 6, 2014, May 6, 2015, May 6, 2016 and May 6, 2017. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	24,928	Not disclosed Strike: $11.48	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 7 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,928 shares Expires 2022-03-06 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F12 · derivative.exercise_date: All of the options are time-based options which, as of March 6, 2016, were fully vested. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	23,696	Not disclosed Strike: $13.94	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 6 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,696 shares Expires 2022-03-06 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F11 · derivative.exercise_date: All of the options are time-based options which, as of March 6, 2013, were fully vested. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	1,951	Not disclosed Strike: $8.72	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 5 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,951 shares Expires 2021-02-08 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F10 · derivative.exercise_date: All of the options are time-based options which, as of February 8, 2016, were full vested. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	37,765	Not disclosed Strike: $12.10	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 4 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,765 shares Expires 2019-07-23 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F9 · derivative.exercise_date: This line contains a combination of both time-based and performance-based options which, as of September 16, 2013, were fully vested. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerOptions to Purchase Common Stock · Derivative	53,500	Not disclosed Strike: $12.10	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · derivative · entry 3 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,500 shares Expires 2018-09-15 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F8 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding SCA stock option was cancelled and converted into an option to purchase UHG common stock (rounded down to the nearest whole number) equal to the product of (x) the number of shares subject to such SCA stock option immediately prior to the Effective Time and (y) the Equity Award Conversion Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such SCA stock option immediately prior to the Effective Time divided by (B) the Equity Award Conversion Ratio. F7 · derivative.exercise_date: This line contains a combination of both time-based and performance-based options which, as of September 16, 2013, were fully vested. Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Disposition to issuerCommon Stock	66,750	Not disclosed	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · nonDerivative · entry 2 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · kind: Disposed of in the Merger, pursuant to the Merger Agreement F5 · price: Pursuant to the Merger Agreement, at the Effective Time each share of Common Stock was cancelled and converted into the right to receive $11.40 in cash and a number of shares of UHG common stock equal to $45.60 divided by $169.42, (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer), with the fractional shares being paid in cash, as provided in the Merger Agreement. F6 · price: Pursuant to the Merger Agreement, at the Effective Time each outstanding and unvested RSU was cancelled and converted into that number of RSUs (rounded down to the nearest whole share) in respect of UHG common stock equal to the product of (x) the number of shares subject to such RSU immediately prior to the Effective Time and (y) $57 divided by $169.42 (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer) rounded down to the nearest whole share (such quotient, the "Equity Award Conversion Ratio"). Read SEC document
March 24, 2017 Filed Mar 24, 2017 21:40 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	OtherCommon Stock	30,934	Not disclosed	Not disclosed	Disclosure SEC source: 0000903423-17-000229 · rucker.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,750 F1 · kind: Disposed of in the exchange offer by Spartan Merger Sub 1, Inc. to acquire all of the outstanding shares of Common Stock (the "Exchange Offer"), pursuant to the Agreement and Plan of Reorganization, dated January 7, 2017, (the "Merger Agreement," and the merger contemplated thereby, the "Merger") by and among Surgical Care Affiliates, Inc. ("SCA"), UnitedHealth Group Incorporated ("UHG"), Spartan Merger Sub 1, Inc., and Spartan Merger Sub 2, LLC. F2 · price: Pursuant to the Merger Agreement, each share of Common Stock was exchanged for $11.40 in cash and a number of shares of UHG common stock equal to $45.60 divided by $169.42, (which represents the volume weighted average of the closing sale prices per share of UHG common stock on the New York Stock Exchange on each of the five full consecutive trading days ending on and including March 21, 2017, the third business day prior to the final expiration date of the Exchange Offer), with the fractional shares being paid in cash, as provided in the Merger Agreement. F3 · balance_after: Includes 53,965 shares of Common Stock underlying restricted stock units ("RSUs") of the issuer, all of which are subject to time-based vesting and remained unvested mmediately prior to the effective time of the Merger (the "Effective Time"). Each RSU represents a contingent right to acquire one share of Common Stock. Read SEC document
March 02, 2017 Filed Mar 6, 2017 17:02 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	GrantOptions to Purchase Common Stock · Derivative	14,396	$0.00 Strike: $56.64	$0.00	Disclosure SEC source: 0001590503-17-000059 · edgar.xml · derivative · entry 12 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,396 Underlying: Common Stock · 14,396 shares Expires 2027-03-02 F13 · kind: Grant of options to purchase shares of Common Stock of the issuer pursuant to the Plan, which is exempt under Rule 16b-3(d) of the Exchange Act. F14 · derivative.exercise_date: The option provides for vesting in equal annual installments on March 2, 2018, March 2, 2019, March 2, 2020 and March 2, 2021. Read SEC document
March 02, 2017 Filed Mar 6, 2017 17:02 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	GrantCommon Stock	12,138	$0.00	$0.00	Disclosure SEC source: 0001590503-17-000059 · edgar.xml · nonDerivative · entry 2 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,684 F2 · shares: Grant of restricted stock units of the issuer, vesting ratably in equal annual installments over a period of four years from March 2, 2017, pursuant to the Surgical Care Affiliates, Inc. 2016 Omnibus Long-Term Incentive Plan (the "Plan"), which is exempt under Rule 16b-3(d) of the Exchange Act. F3 · balance_after: Includes 53,965 shares of Common Stock underlying restricted stock units ("RSUs") of the issuer, all of which are subject to time-based vesting. The RSUs vest on the following schedule and are settled on each applicable vesting date: 5,297 RSUs vesting on June 4, 2017, 6,719 RSUs vesting on September 17, 2017, 7,202 RSUs vesting on March 2, 2018, 5,296 RSUs vesting on June 4, 2018, 6,719 RSUs vesting on September 17, 2018, 7,202 RSUs vesting on March 2, 2019, 5,296 RSUs vesting on June 4, 2019, 7,200 RSUs vesting on March 2, 2020 and 3,034 RSUs vesting on March 2, 2021. Read SEC document
March 02, 2017 Filed Mar 6, 2017 17:02 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Tax withholdingCommon Stock	1,713	$56.64	$97,024.32	Disclosure SEC source: 0001590503-17-000059 · edgar.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,546 F1 · shares: Represents shares of Common Stock withheld by the issuer to satisfy tax withholding obligations incident to the vesting and settlement on March 2, 2017 of restricted stock units of the issuer previously issued in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such deemed disposition is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e). Read SEC document
September 17, 2016 Filed Sep 20, 2016 14:48 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Tax withholdingCommon Stock	3,072	$40.68	$124,968.96	Disclosure SEC source: 0001590503-16-000112 · edgar.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,259 F1 · shares: Represents shares of Common Stock withheld by the issuer to satisfy tax withholding obligations incident to the vesting and settlement on September 17, 2016 of restricted stock units of the issuer previously issued in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such deemed disposition is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-3(e). F2 · balance_after: Includes 45,994 shares of Common Stock underlying restricted stock units ("RSUs") of the issuer. All of the RSUs vest on the following schedule and are settled on each applicable vesting date: 4,167 RSUs vesting on March 2, 2017, 5,297 RSUs vesting on June 4, 2017, 6,719 RSUs vesting on September 17, 2017, 4,167 RSUs vesting on March 2, 2018, 5,296 RSUs vesting on June 4, 2018, 6,719 RSUs vesting on September 17, 2018, 4,167 RSUs vesting on March 2, 2019, 5,296 RSUs vesting on June 4, 2019 and 4,166 RSUs vesting on March 2, 2020. Read SEC document
September 06, 2016 Filed Sep 8, 2016 13:19 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Exercise / conversionOptions to Purchase Common Stock · Derivative	17,500	$0.00 Strike: $11.48	$0.00	Disclosure SEC source: 0001590503-16-000108 · edgar.xml · derivative · entry 7 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,928 Underlying: Common Stock · 17,500 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: All of the options are time-based options which, as of March 6, 2016, were full vested. Read SEC document
September 06, 2016 Filed Sep 8, 2016 13:19 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	SaleCommon Stock	17,500	$42.56	$744,800.00	Disclosure SEC source: 0001590503-16-000108 · edgar.xml · nonDerivative · entry 2 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,331 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2015, which plan became effective November 6, 2015. F3 · price: This price represents the weighted average sale price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $42.37 to $42.62. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. F1 · balance_after: Includes 52,714 shares of Common Stock underlying restricted stock units ("RSUs") of the issuer. All of the RSUs vest on the following schedule and are settled on each applicable vesting date: 6,720 RSUs vesting on September 17, 2016, 4,167 RSUs vesting on March 2, 2017, 5,297 RSUs vesting on June 4, 2017, 6,719 RSUs vesting on September 17, 2017, 4,167 RSUs vesting on March 2, 2018, 5,296 RSUs vesting on June 4, 2018, 6,719 RSUs vesting on September 17, 2018, 4,167 RSUs vesting on March 2, 2019, 5,296 RSUs vseting on June 4, 2019 and 4,166 RSUs vesting on March 2, 2020. Read SEC document
September 06, 2016 Filed Sep 8, 2016 13:19 UTC	Surgical Care Affiliates, Inc. SCAI · Entity 177510	Exercise / conversionCommon Stock	17,500	$11.48	$200,900.00	Disclosure SEC source: 0001590503-16-000108 · edgar.xml · nonDerivative · entry 1 Rucker Michael A. · CIK 0001588247 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 52,714 shares of Common Stock underlying restricted stock units ("RSUs") of the issuer. All of the RSUs vest on the following schedule and are settled on each applicable vesting date: 6,720 RSUs vesting on September 17, 2016, 4,167 RSUs vesting on March 2, 2017, 5,297 RSUs vesting on June 4, 2017, 6,719 RSUs vesting on September 17, 2017, 4,167 RSUs vesting on March 2, 2018, 5,296 RSUs vesting on June 4, 2018, 6,719 RSUs vesting on September 17, 2018, 4,167 RSUs vesting on March 2, 2019, 5,296 RSUs vseting on June 4, 2019 and 4,166 RSUs vesting on March 2, 2020. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.